Clasado Biosciences (Clasado), a global leader in the development of clinically proven prebiotic ingredients and product solutions for the human gut microbiome, has underlined its commitment to advancing knowledge in the prebiotic market with the launch of its brand new website.
The responsive new site elaborates on the strong portfolio of research behind the company’s flagship ingredient Bimuno with simplified navigation and a contemporary look. Visitors will find more information on the patent-protected product, which is a unique blend of galactooligosaccharides, with its efficacy supported by human trials, in vivo and in vitro studies.
CLASADO website SMALLIncorporating the significant clinical evidence behind the company's flagship ingredient Bimuno, as well as outlining why the patented second-generation prebiotic is a flexible and powerful addition to functional food and drink applications, the site demonstrates the new look and identity of Clasado, in line with the recently launched branding strategy for business customers.
Our new contemporary website creates a core information point for our existing and new business partners, as well as enabling intuitive access to our news, events and latest informatio
The modern, streamlined design boosts the functionality and user experience with improved access to important information, including the significant portfolio of clinical studies behind the technology and the benefits of Bimuno for healthcare professionals.
Per Rehné, CEO at Clasado, commented: "We’re thrilled to debut our new corporate website alongside our fresh branding. Our focus is on delivering strong science and cutting-edge technology that makes a real difference to consumers. Our new contemporary website creates a core information point for our existing and new business partners, as well as enabling intuitive access to our news, events and latest information."
"This market doesn’t stay still for long and the prebiotics category is growing at a rapid pace around the world, including with the development of synbiotics. We have seen this expansion first-hand with Bimuno and are keen to ensure we have the right support in place for our customers; this launch is a key strategic step for our business. Importantly, visitors can find the studies that support the efficacy of Bimuno, as well as meeting the talented team behind it."
Visit the new site here
